Michael Levy

Michael Levy is Senior Vice President, Digital and Innovation. In this role, Mr. Levy oversees several forward-looking pillars of activity, including Research and Innovation, Digital & Informatics, and the Pharmaceutical Supply Chain Center.

Research & Innovation identifies, assesses, and as appropriate, incubates emerging technologies that may impact the industries USP works in, the way USP standards are used, or the way those standards are produced.

Digital & Informatics focuses on digitizing USP’s standards to better integrate them into digital environments, fostering standards for digital solutions, and enhancing USP’s digital delivery of content.

The Pharmaceutical Supply Chain Center leverages a unique, integrated data set and analytics to explore complex medicine supply chains, identify potential vulnerabilities, and recommend risk mitigating interventions.

Mr. Levy’s diverse background includes shaping public policy through advocacy, counseling biopharmaceutical and healthcare regulatory executives and staff as a management consultant, and providing deep scientific and technical expertise to academic and industry researchers. Prior to his current role, Mr. Levy was the creator and first Head of USP’s Quality Institute. Previously, he served as Deputy Vice President, Science & Regulatory Advocacy, at the Pharmaceutical Research and Manufacturers of America (PhRMA), where he shaped the drug development and regulatory review processes—with an emphasis on using non-traditional data and advanced analytics to inform clinical trial design and regulatory decision making. Mr. Levy also served as an Associate Principal at McKinsey & Company, where he supported biopharmaceutical companies and regulators on a broad set of topics in Research and Development and technology enablement. Earlier in his career, Mr. Levy was part of the team that sequenced Human Chromosome XIV as part of the Human Genome Project, and he was the lead bioinformatician in a bioinformatics start-up.

Mr. Levy earned his Masters of Business Administration Degree from Cornell University’s Johnson Graduate School of Management, and his Master of Science and Bachelor of Science degrees from Concordia University in Montreal, Canada.